Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Benralizumab In the Treatment of Eosinophilic Grandulomatosis With Polyangiitis (EGPA) Study: BITE

NCT03010436 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.

NCT NCT03010436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03010436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Benralizumab In the Treatment of Eosinophilic Grandulomatosis With Polyangiitis (EGPA) Study: BITE
Lead sponsor
National Jewish Health
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 15, 2017
Completion date
December 31, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma